Metabolic syndrome: Difference between revisions

No edit summary
 
(23 intermediate revisions by 4 users not shown)
Line 1: Line 1:
'''<big>'Background</big>'''
==Background==
------------------------------------------------------------------------------------------------
*Prothrombotic, proimflammatory state
Cluster of conditions characterize by:
*May be associated with elevated CRP, IL-6, and tissue plasminogen activator, which may be associated with increased risk of cardiovascular disease and type 2 diabetes
* 1. Increase blood pressure
**Markers not shown to be of utility in the ED
* 2. Increase body fat around the waist
* 3. Abnormal cholesterol or triglycerides


*Leading to Increase Risk of Heart disease, Stroke or Diabetes
==Clinical Features==
''Although several diagnostic features exist, below is the most widely accepted: The National Cholesterol Education Program (NCEP) Adult Treatment Panel III (ATP III)''
*'''Diagnostic Criteria''' - 3 or more of the following:
**Waist circumference >/=102 cm in men or >/=88 cm in women
**Plus 3 of the following:
**Fasting blood glucose >/= to 100 mg/dL or requiring treatment for elevated blood glucose
**HDL </=40 in men or </=50 in women
**TGs >/=150 mg/dL
**BP >/= 130/85 or requiring drug treatment for HTN


<big>'''Diagnostics'''</big>
==Differential Diagnosis==
-------------------------------------------------------------------------------------------------
*[[Hypertension]]
Diagnosis is base on three or more of the following or if taking any medication to control disease.
*Hyperlipidemia
*[[Hyperglycemia]]
*[[Hypothyroidism]]
*Obstructive Sleep Apnea
*Type 2 [[DM]]
*[[Pheochromocytoma]]
*Glucagonoma


* Large waist circumference — At least 35 inches (89 centimeters) for women and 40 inches for men
==Evaluation==
* High triglyceride level — 150 mg/dL or 1.7 mmol/L
*Not an ED diagnosis!
* Reduced high-density lipoprotein (HDL) cholesterol — less than 40 mg/dL (1.04 mmol/L) in men or less than 50 mg/dL (1.3 mmol/L) in women of this "good" cholesterol
*Evaluate for sequelae of associated diseases (e.g. cardiovascular disease, DM) as appropriate
* Increased blood pressure — 130/85 or higher
*Non-ED workup may include:
* Elevated fasting blood sugar — 100 mg/dL or higher
**BMP
**HbA1c
**Lipid panel
**TSH
**+/- Polysomnography to evaluate for OSA


'''<big>Treatment</big>'''
==Management==
-------------------------------------------------------------------------------------------------
*Lifestyle modification
*[[Metformin]]
*BP control(e.g. [[ACEi]] or ARBs}
*OSA treatment
*Depending on the level of obesity, and severity of the condition bariatric surgery may be advantageous to the patient
*Possible referral to obesity management clinic
 
==Disposition==
*Discharge with outpatient follow-up
 
==External Links==
 
 
==References==
<references/>


* The first line of treatment is Life Style changes
* 2nd: Medication to control disease
* HTN overview- http://wikem.org/wiki/Asymptomatic_hypertension
* DM overview- http://wikem.org/wiki/Diabetes_mellitus_(main)
* Stroke overview- http://wikem.org/wiki/Stroke_(main)
--------------------------------------------------------------------------------------------------
[[Category:Endocrinology]]
[[Category:Endocrinology]]

Latest revision as of 07:24, 18 August 2022

Background

  • Prothrombotic, proimflammatory state
  • May be associated with elevated CRP, IL-6, and tissue plasminogen activator, which may be associated with increased risk of cardiovascular disease and type 2 diabetes
    • Markers not shown to be of utility in the ED

Clinical Features

Although several diagnostic features exist, below is the most widely accepted: The National Cholesterol Education Program (NCEP) Adult Treatment Panel III (ATP III)

  • Diagnostic Criteria - 3 or more of the following:
    • Waist circumference >/=102 cm in men or >/=88 cm in women
    • Plus 3 of the following:
    • Fasting blood glucose >/= to 100 mg/dL or requiring treatment for elevated blood glucose
    • HDL </=40 in men or </=50 in women
    • TGs >/=150 mg/dL
    • BP >/= 130/85 or requiring drug treatment for HTN

Differential Diagnosis

Evaluation

  • Not an ED diagnosis!
  • Evaluate for sequelae of associated diseases (e.g. cardiovascular disease, DM) as appropriate
  • Non-ED workup may include:
    • BMP
    • HbA1c
    • Lipid panel
    • TSH
    • +/- Polysomnography to evaluate for OSA

Management

  • Lifestyle modification
  • Metformin
  • BP control(e.g. ACEi or ARBs}
  • OSA treatment
  • Depending on the level of obesity, and severity of the condition bariatric surgery may be advantageous to the patient
  • Possible referral to obesity management clinic

Disposition

  • Discharge with outpatient follow-up

External Links

References